Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Shares, par value CHF 0.08 per share · CUSIP: H0036K147

Event date: 2025-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • HPWH TH AG

    Shares: 8,670,588.00 · Class: 8.52%

  • Dr. Hans-Peter Wild

    Shares: 9,788,944.00 · Class: 9.61%

  • Thomas Pfisterer

    Shares: 173,899.00 · Class: 0.17%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001731122-25-000783
Form type
SCHEDULE 13G/A
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
May 19, 2025
Reporting period
May 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub